Austria · Startup
Austria · Themis Bioscience GmbH
Themis is a biopharmaceutical company that develops and commercializes immunomodulation therapies for the treatment of infectious diseases and cancer.
Funding reportedLast round: Grant
What company datasets say Themis Bioscience GmbH raised
Funding, as reported
Reported in all150.2Min the source's currency
Rounds11
Last roundGrant
Last round size44M
Last round dateMar 2020
Investors listed13
On a portfolio page
Investors who name them
Each firm lists Themis Bioscience GmbH on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
- Region
- Vienna
- Part of
- Merck
- Revenue
- 6.8M a year, as listed
- Full record
- Every detail in the company directory
Is this your company?
Add your raise, your deck and your story, and put Themis Bioscience GmbH in front of investors. Or tell us what we have wrong.